Antimicrobials

At 8-10 days of cumulative aminoglycoside therapy, pharmacist will discuss with patient the signs and symptoms of ototoxicity and provide a patient information sheet containing their contact information. After counselling patient, pharmacist will record the following documentation in the History and Progress notes of medical record:

• Date
• Pharamacy Note:
• Patient has been counseled about aminoglycoside therapy and provided with a patient information sheet, as per MAC approved ototoxicity protocol.
• Pharmacist's Signature (Print name and include pager number)

After 13-15 days of cumulative aminoglycoside therapy, if treatment is to continue, pharmacist will write the following in the Doctor's Orders Section of the medical record:

As per MAC approved policy, Pharmacy Suggests: Patient has received --- days of aminoglycoside therapy. Auditory and vestibular testing to be done as follows:

• STAT baseline audiogram*
• STAT baseline ENG# (if patient is transportable)
• MD to document in patient's medical record progress notes if patient is not transportable
• Please co-sign order if approved
• MD to inform ENT clinic of these orders at telephone extension x4138
• Pharmacist's signature (Print name and include pager number)

Repeat audiogram and ENG to be done any time signs of ototoxicity become apparent. In addition, ENT will schedule repeat tests 14-21 days after baseline tests, if indicated.